Patent · US Active

Anti-Jagged1 antigen binding proteins

US11028180B2 · kind B2 · utility

1Cited by
57References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2018
Grant dateJun 8, 2021
Priority date
Expiry dateJul 13, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treating conditions related to lung disease using an antigen binding protein specific for the Jagged1 polypeptide are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.